PLK1 and urinary bladder carcinoma: The exosomes that are derived from MSC and HEK293 were used to deliver siRNA that target PKL-1 in bladder cancer cells and showed the reduced expression of polo-like kinase 1 (PLK-1) [158] (Fig. 4).